Earnings History Data for Enlivex Therapeutics (ENLV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Enlivex Therapeutics

Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
29-04-2022 PM ENLV Enlivex Therapeutics 103.00 -0.26 -0.28 0.00 5.64 -0.17 
(-2.93%)
5.49 -0.32 
(-5.51%)
4.76 - 13.95 159,835 60,000 458
09-08-2021 PM ENLV Enlivex Therapeutics Ltd. 131.00 -0.17 -0.26 0.00 Envilex Therapeutics reports Q2 results
[8/9/2021 8:57 AM]
9.74 1.47 
(17.78%)
9.12 0.85 
(10.28%)
4.49 - 29.40 317,176 70,000 7,999